WEAKID | Clinical validation of miniature wearable dialysis machine
01-01-2017
-30-06-2019
Projects overview
23 items found
anTBiotic | AnTBiotic – progressing TB drug candidates to clinical proof of concept
01-01-2017
-30-06-2022
Soraprazan | Soraprazan - a new regenerative therapy for Stargardt's disease
01-12-2017
-30-11-2021
Show more information
EU-Programme-Call
OSTEOproSPINE | Novel Bone Regeneration Drug Osteogrow: Therapeutic Solution for Lumbar Back Pain
01-01-2018
-30-06-2023
Show more information
EU-Programme-Call
LIVERHOPE | SIMVASTATIN AND RIFAXIMIN AS NEW THERAPY FOR PATIENTS WITH DECOMPENSATED CIRRHOSIS
01-01-2017
-28-02-2023
HIVACAR | Evaluating a Combination of Immune-based Therapies to Achieve a Functional Cure of HIV Infection
01-01-2017
-30-06-2022
RESPINE | REgenerative therapy of intervertebral disc: a double blind phase 2b trial of intradiscal injection of mesenchymal stromal cells in degenerative disc disease of the lomber SPINE unresponsive to conventional therapy
01-01-2017
-30-06-2023
Show more information
EU-Programme-Call
PAPA-ARTIS | Paraplegia Prevention in Aortic Aneurysm Repair by Thoracoabdominal Staging with ‘Minimally-Invasive Segmental Artery Coil-Embolization’: A Randomized Controlled Multicentre Trial
01-01-2017
-30-09-2024
IMMUNISA | A Next Generation Immunotherapy for Human Papilloma Virus induced Cervical Cancer
01-12-2017
-30-11-2022
STIPED | Transcranial brain stimulation as innovative therapy for chronic pediatric neuropsychiatric disorder – STIPED
01-01-2017
-30-06-2022
HIPGEN | Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial
01-01-2018
-30-09-2022
Show more information
EU-Programme-Call
IMMUNOSABR | Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer
01-01-2017
-31-12-2024
ALIVER | Development of DIALIVE, a novel Liver Dialysis Device for the treatment of patients with Acute on Chronic Liver Failure (ACLF)
01-01-2017
-31-01-2021
EURE-CART | EURopean Endeavour for Chimeric Antigen Receptor Therapies
01-01-2017
-30-06-2021
MAXIBONE | Personalised maxillofacial bone regeneration
01-01-2018
-30-06-2022
Show more information
EU-Programme-Call
RESTORE | NEURONAL SELF-RENEWAL BY ANTIGEN-SPECIFIC TOLERIZATION IN MULTIPLE SCLEROSIS REINSTALLING THE BALANCE BETWEEN INFLAMMATION AND REGENERATION
01-01-2018
-30-06-2023
Show more information
EU-Programme-Call
KidsAP | The artificial pancreas in children aged 1 to 7 years with type 1 diabetes
01-01-2017
-31-12-2021
ORTHOUNION | ORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft in long bone nonUNIONs
01-01-2017
-30-06-2022
Show more information
EU-Programme-Call
ReGenHeart | Clinical development and proof of principle testing of new regenerative VEGF-D therapy for cost-effective treatment of refractory angina A phase II randomized, double-blinded, placebo-controlled study
01-01-2017
-31-12-2022
Show more information
EU-Programme-Call
PACE | A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies
01-01-2017
-31-12-2021
Show more information
EU-Programme-Call
MUSIC | Multisystem Cell Therapy for Improvement of Urinary Continence
01-01-2017
-31-03-2022
Show more information
EU-Programme-Call
TreatER | Clinical study in Parkinson's disease with two unique goals: 1) Proof-of-concept of CDNF protein for disease modification; 2) Validation of clinically tested device for intracerebral drug delivery
01-01-2017
-31-12-2020
PROOF | Penumbral Rescue by Normobaric O=O Administration in Patients With Ischaemic Stroke and Target Mismatch ProFile: A Phase II Proof-of-Concept Trial
01-01-2017
-30-06-2023